Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Establishing Our Foundation of LGMD2I/R9
John Vissing, MD, DMSci
Conrad Weihl, MD, PhD
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
Recognizing Early Signs of LGMD2I/R9
Navigating the LGMD2I/R9 Diagnostic Pathway
The Role of Multidisciplinary Care in LGMD2I/R9
Advancing Care: Clinical Innovations on the Horizon
Optimizing Patient Management Strategies
Integrating Perspectives: The Value of Patient and Caregiver Input
Bridging Gaps in LGMD Care
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
Alejandro A. Rabinstein, MD, FAHA
Richard E. Pratley, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.